Vivani Medical Files 8-K, Confirms Nasdaq Listing
Ticker: VANI · Form: 8-K · Filed: Jan 10, 2024 · CIK: 1266806
Complexity: simple
Sentiment: neutral
Topics: administrative, corporate-governance, exchange-listing
TL;DR
**Vivani Medical filed a routine 8-K, confirming its Nasdaq listing; no major news.**
AI Summary
Vivani Medical, Inc. filed an 8-K on January 10, 2024, reporting an event that occurred on January 9, 2024. This filing is a standard 'Other Events' report, indicating a disclosure of information not covered by other specific 8-K items. For investors, this filing primarily serves to update administrative details, such as confirming its Nasdaq Capital Market listing under the ticker VANI, and does not contain new financial or operational news that would immediately impact stock valuation.
Why It Matters
This filing confirms Vivani Medical's continued listing on the Nasdaq Capital Market, which is important for liquidity and investor confidence. It doesn't contain new material financial information, so its direct impact on stock price is likely minimal.
Risk Assessment
Risk Level: low — This 8-K is a routine administrative filing and does not disclose any new risks or significant operational changes for Vivani Medical, Inc.
Analyst Insight
A smart investor would note this as a routine administrative update, confirming the company's listing status, but would not expect any immediate stock price movement based solely on this filing. Further research into Vivani Medical's operational updates or financial performance would be necessary for investment decisions.
Key Players & Entities
- Vivani Medical, Inc. (company) — the registrant filing the 8-K
- Nasdaq Capital Market (company) — the exchange where Vivani Medical's common stock is registered
- VANI (other) — the trading symbol for Vivani Medical's common stock
- January 9, 2024 (date) — the date of the earliest event reported in the 8-K
- January 10, 2024 (date) — the filing date of the 8-K
FAQ
What is the purpose of this 8-K filing by Vivani Medical, Inc.?
This 8-K filing by Vivani Medical, Inc. is categorized under 'Other Events' and 'Financial Statements and Exhibits,' primarily serving to report an event that occurred on January 9, 2024, and to confirm administrative details such as its registration on the Nasdaq Capital Market.
What is Vivani Medical, Inc.'s trading symbol and where is its common stock registered?
Vivani Medical, Inc.'s common stock trades under the symbol VANI and is registered on the Nasdaq Capital Market, as stated in the filing under 'Securities registered pursuant to Section 12(b) of the Act'.
When was the earliest event reported in this 8-K filing?
The earliest event reported in this 8-K filing occurred on January 9, 2024, as indicated by 'Date of Report (Date Earliest Event Reported): January 9, 2024'.
What is the business address and phone number of Vivani Medical, Inc.?
Vivani Medical, Inc.'s principal executive offices are located at 1350 S. Loop Road, Alameda, California 94502, and its telephone number is (415) 506-8462, according to the filing.
Is Vivani Medical, Inc. considered an emerging growth company according to this filing?
The filing includes a checkbox section asking 'Indicate by check mark whether the registrant is an emerging growth company...', but the box is not checked, implying that Vivani Medical, Inc. does not identify itself as an emerging growth company for the purposes of this filing.
Filing Stats: 523 words · 2 min read · ~2 pages · Grade level 12.2 · Accepted 2024-01-10 16:30:36
Key Financial Figures
- $0.0001 — f the Company's common stock, par value $0.0001 per share (the "Common Stock"), had clo
- $1.00 — ow the minimum bid price requirement of $1.00 per share for continued listing on The
Filing Documents
- g083943_8k.htm (8-K) — 32KB
- 0001753926-24-000087.txt ( ) — 198KB
- vani-20240109.xsd (EX-101.SCH) — 3KB
- vani-20240109_lab.xml (EX-101.LAB) — 33KB
- vani-20240109_pre.xml (EX-101.PRE) — 22KB
- g083943_8k_htm.xml (XML) — 3KB
01 Other Events
Item 8.01 Other Events. As previously disclosed, on December 26, 2023, Vivani Medical, Inc. (the "Company") received a written notice from the Listing Qualifications Department of The Nasdaq Stock Market, LLC ("Nasdaq") notifying the Company that, for 30 consecutive trading days from November 9, 2023 through December 21, 2023, the closing bid price of the Company's common stock, par value $0.0001 per share (the "Common Stock"), had closed below the minimum bid price requirement of $1.00 per share for continued listing on The Nasdaq Capital Market pursuant to Nasdaq Listing Rule 5550(a)(2). On January 9, 2024, the Company received a letter from Nasdaq notifying the Company that it had regained compliance with Nasdaq Listing Rule 5550(a)(2), because for the last 10 consecutive business days, from December 22, 2023, through January 8, 2024, the closing bid price of the Company's Common Stock had been at $1.00 per share or greater. Accordingly, the Company has regained compliance with Nasdaq Listing Rule 5550(a)(2) and Nasdaq considers this matter closed. Item 9.01 Financial Statements and Exhibits. (d) Exhibits No. Description of Exhibit 104 Cover Page Interactive Data File (embedded within the Inline XBRL document)
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. VIVANI MEDICAL, INC. Date: January 10, 2024 By: /s/ Brigid Makes Brigid Makes Chief Financial Officer (Principal Financial and Accounting Officer)